naturalX Health Ventures is a €100 million investment fund backed by Schwabe Group, a self-described global leader in plant-based pharmaceuticals. The fund invests in innovative, young companies in the field of consumer health.

naturalX Health Ventures

naturalX Health Ventures is the €100mio VC arm of Schwabe Group for its investments in innovative, young companies as well as relevant VC funds.
We are flexible and can invest from seed to late stage. Our focus lies on Series A and Series B investments, where strong signs of product-market fit can be shown. 
We invest into consumer healthcare and are particularly excited about mental health as well as proactive health, including sleep, nootropics, nutrition, prevention & longevity, bio-hacking, consumer diagnostics and more. We do not invest into biotech or medtech at this stage.
Schwabe Group, our parent company, is a global leader in plant-based pharmaceuticals with about €950 million in revenue mainly across Europe and North America.
The aim of investing is to combine the growth potential of young, innovative companies with the financial strength and access to different expertise of our parent company. We are a strategic-financial investor.

We have been under the radar and plan to slowly change this. Yesterday, we hosted our first event together with Calm/Storm in Amsterdam as part of the HLTH Europe.

Hey there, HealthTech enthusiasts! 👋

Will you be in #Amsterdam next week for HLTH Europe? 

Join us for breakfast with our friends at naturalX Health Ventures! 🥐☕ Whether you’re a VC, founder, or industry veteran, we hope to see you there. We still have a few spaces left, so it’s not too late to register.

📅 Date: 18th June
⏰ Time: 8:45am-11am
📍 Location: The Hoxton, Amsterdam

Register here 👉 https://lnkd.in/dAh7jfFF and reach out to Johannes Blaschke, Carina Roth, Lucanus ⛵️ Polagnoli, or Ekaterina Gianelli to connect at the conference!

cc: Amazon Web Services (AWS) Guy Spigelman ABA - INVEST in AUSTRIA Gerlinde Gahleitner Verena Gruber Marion Biber

#HLTHAmsterdam #HealthTech #Networking #BreakfastEvent #Innovation #CalmStorm #naturalXHealthVentures

We are co-hosting a Networking Breakfast on June 18th at HLTH Europe together with our from Calm/Storm. Register here to secure one of the spots ➡️ https://lnkd.in/dy2FmFXX

I was honored to participate in the inaugural Lakestar Healthcare Symposium last week, alongside 50 esteemed entrepreneurs, regulators, and investors from the healthcare industry, including former Minsters of Health Jens Spahn, Dr. Philipp Rösler, and Daniel Bahr. Many thanks to Oliver Heimes for the invitation.

Held at the Berlin Museum of Medical History at the Charité in Berlin, the symposium provided sharp and thought-provoking insights about the German political landscape and the state of digitisation in healthcare.

One key takeaway for me was the perspective of insurers on prevention. While many envision a transition from sick care to healthcare, the reallocating funds from disease treatment to prevention (and longevity), insurers remain skeptical on this topic.

For insurers, the financial equation must make sense. Does a customer truly cost less if they engage in preventative care? Or does an increase in lifespan result in higher costs? Perhaps, ironically, the most profitable scenario is a customer who lives unhealthily and passes away prematurely...

For the April edition of Longevity Wednesdays, we brought together a stellar lineup of scientists, entrepreneurs, and investors in the longevity space for an invite-only dinner just outside Lisbon, sponsored by naturalX Health Ventures.

With the vision of fostering a vibrant community in Lisbon, Nina Patrick, PhD, Michele Gallia, and I launched Longevity Wednesdays last year. Our aim? To connect like-minded professionals passionate about advancing the field of longevity. Stay tuned for more exciting events to come! #Longevity #Lisbon 

Thank you everyone for coming! 

Pedro de Noronha Pissarra
Adrienne Alyzee
Pedro "Henrich" Azevedo
Maria Corlianò, Ph.D.
Joël Palix
Yang C.
Jeffrey Krone
Clara Burtenshaw
Tamsin Chislett
Dr. Sabine Krofczik-Wilhelm
Sebastian Rinnebach

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 20, 2024 6:24 PM	bde42151
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 20, 2024 6:24 PM	9015b96b
translate crunchbase fundingrounds	general
peers	general	Aug 20, 2024 6:24 PM	74622565
news basic	general	Aug 20, 2024 6:24 PM	e08a3d90
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NATU

VC:NATURALX

naturalX Health Ventures